IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the unveiling of the BIOLASE Learning Center, a state-of-the-art learning facility designed to provide a comprehensive laser training experience for dental professionals. The new learning center will allow BIOLASE to offer more laser training courses on-site at its headquarters in Irvine.
The BIOLASE Learning Center, a 4,587-square-foot facility, houses a main lecture hall that seats more than 50, a fully equipped, hands-on laser lab featuring the company’s latest best-in-class laser solutions, as well as group meeting rooms, a business center for guests, and a kitchen/café.
The Hands-On Laser Lab features a WaterLase® iPlus all-tissue laser and EPIC™ X diode laser at each station, along with the capability for live video demonstrations with the built-in monitors at each station.
“A key part of our go-forward strategy in the transformation of BIOLASE is to offer in-depth training and support for our customers to ensure they fully understand how our systems can improve patient outcomes and help them achieve their patient and business goals,” said President and CEO Harold C. Flynn, Jr. “Our new learning center creates an environment that supports the educational needs of the dental community, by developing high-valued educational offerings that promote life-long learning and provides our customers with the tools and skills to provide better dentistry for their patients. With the launch of the BIOLASE Learning Center, we have raised the bar for our customers and affiliated institutions such as the World Clinical Laser Institute and regional dental schools that require laser education capabilities beyond what their university can provide.”
There are more than 20 laser courses planned to take place at the BIOLASE Learning Center this year.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers. BIOLASE's products are focused on technologies that advance the practice of dentistry and medicine and offer benefits and value to healthcare professionals and their patients. The Company's proprietary laser products incorporate approximately 340 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 30,500 laser systems. Laser products under development address the Company's core dental market and other adjacent medical and consumer markets.
For updates and information on WaterLase® iPlus™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.
BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements contained in this press release that refer to BIOLASE's estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements in this press release concerning prospects related to BIOLASE's strategic initiatives and anticipated financial performance. Forward-looking statements can also be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations regarding existing trends, our strategic initiatives, the closing of the private placement and expected use of proceeds and speak only as of the date of this release. Actual results may differ materially from BIOLASE’s current expectations depending upon a number of factors affecting BIOLASE’s business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that may be detailed, from time-to-time, in BIOLASE's reports filed with the SEC. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements contained herein.